HomeTrialNCT05166161
🔬NCT05166161Phase 3ACTIVE NOT RECRUITING

A Long-Term Safety Study of PTC923 in Participants With Phenylketonuria

Study Summary

The main purpose of this study is to evaluate the long-term safety of PTC923 in participants with phenylketonuria, and to evaluate the changes from baseline in dietary phenylalanine (Phe)/protein consumption.

Conditions
Interventions / Drugs
View on ClinicalTrials.gov ↗
Study Details
Enrollment200 participants
Primary Completion
Lead SponsorPTC Therapeutics
Data Retrieved2026-04-11 04:25:04.378905+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.